This approval marks a potential turning point in the management of multiple myeloma, a complex and often challenging cancer ...

Patricia Wong struggled with symptoms for months, not knowing that she had multiple myeloma, a rare blood cancer. Now, this ...

In an interview, Amrita Krishnan, MD, discussed several key advancements and challenges in the field of multiple myeloma.

Multiple myeloma, also called myeloma, is a rare blood cancer that involves abnormal growth of plasma cells found in the bone marrow. Healthy plasma cells create Y-shaped proteins called ...

Multiple myeloma is a rare blood cancer that affects your plasma cells. It makes up about 1.8% of all new cancer cases each year and about 10% of all blood cancers. You may not experience symptoms of ...

A research carried out by a group from Cima and the Clínica Universidad de Navarra has described the composition of the ...

Multiple myeloma (MM) is a malignant plasma cell disorder accounting for approximately 10% of all hematologic malignancies. The overall prognosis is driven by tumor biology but other factors such ...

Researchers sought to determine whether a prognostic index utilizing ctDNA would have value in relapsed/refractory multiple ...

Myeloma, or multiple myeloma, is a cancer affecting a particular type of blood cells, called plasma cells. Myeloma is most common in people over 60 and is characterized by the accumulation of ...

Multiple myeloma is a blood cancer that originates in plasma cells, a type of white blood cell found in the bone marrow. Nearly all patients who have multiple myeloma relapse at some point ...

Myeloma, also known as multiple myeloma or plasma cell myeloma, is a cancer of plasma cells that arises in bone marrow. It ...